海森药业
(001367)
| 流通市值：6.58亿 | | | 总市值：25.33亿 |
| 流通股本：1767.21万 | | | 总股本：6800.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 115,797,089.07 | 397,453,269.86 | 283,171,670.7 | 193,368,020.63 |
| 营业收入 | 115,797,089.07 | 397,453,269.86 | 283,171,670.7 | 193,368,020.63 |
| 二、营业总成本 | 77,405,038.6 | 277,738,367.43 | 201,984,375.33 | 140,864,937.5 |
| 营业成本 | 70,512,217.31 | 234,184,822.06 | 169,702,600.18 | 117,988,721.35 |
| 税金及附加 | 892,608.87 | 4,160,810.02 | 2,878,851.47 | 2,096,704.78 |
| 销售费用 | 1,713,996 | 10,461,387.56 | 8,004,482.98 | 5,258,350.11 |
| 管理费用 | 5,070,371.6 | 26,033,175.92 | 20,008,367.33 | 13,866,124.91 |
| 研发费用 | 4,279,248.99 | 18,841,608.1 | 12,416,146.91 | 7,824,667.19 |
| 财务费用 | -5,063,404.17 | -15,943,436.23 | -11,026,073.54 | -6,169,630.84 |
| 其中:利息费用 | 92,261.88 | 33,957.41 | 25,684.68 | 32,487.24 |
| 其中:利息收入 | 4,117,006.63 | 15,298,386.32 | 10,042,614.81 | 5,452,270.37 |
| 加:投资收益 | - | 319,693.15 | - | - |
| 资产处置收益 | - | -241,714.05 | -241,714.05 | -241,714.05 |
| 资产减值损失(新) | -306,990.35 | -2,438,513.67 | -486,705.23 | -411,692.34 |
| 信用减值损失(新) | -54,858.07 | -427,515.5 | -1,576.26 | -828,113.13 |
| 其他收益 | 1,068,696.45 | 5,048,012.88 | 2,882,331.5 | 1,977,837.14 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 39,098,898.5 | 121,974,865.24 | 83,339,631.33 | 52,999,400.75 |
| 加:营业外收入 | 60,800.01 | 8,737.58 | 6,628.58 | 5,983.58 |
| 减:营业外支出 | 260,464.11 | 1,308,248.67 | 472,426.07 | 254,667.98 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 38,899,234.4 | 120,675,354.15 | 82,873,833.84 | 52,750,716.35 |
| 减:所得税费用 | 5,514,464.27 | 16,007,885.59 | 10,947,236.99 | 6,943,042.7 |
| 六、净利润 | 33,384,770.13 | 104,667,468.56 | 71,926,596.85 | 45,807,673.65 |
| 持续经营净利润 | 33,384,770.13 | 104,667,468.56 | 71,926,596.85 | 45,807,673.65 |
| 归属于母公司股东的净利润 | 33,384,770.13 | 104,667,468.56 | 71,926,596.85 | 45,807,673.65 |
| (一)基本每股收益 | 0.49 | 1.68 | 1.19 | 0.81 |
| (二)稀释每股收益 | 0.49 | 1.68 | 1.19 | 0.81 |
| 九、综合收益总额 | 33,384,770.13 | 104,667,468.56 | 71,926,596.85 | 45,807,673.65 |
| 归属于母公司股东的综合收益总额 | 33,384,770.13 | 104,667,468.56 | 71,926,596.85 | 45,807,673.65 |
| 公告日期 | 2024-04-25 | 2024-04-23 | 2023-10-30 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |